🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Materials science company Zerocircle raises pre-Series A round from 3one4 Capital, Rainmatter and others

EntrackrEntrackr · 9d ago
Materials science company Zerocircle raises pre-Series A round from 3one4 Capital, Rainmatter and others
Medial

url: https://entrackr.com/snippets/materials-science-company-zerocircle-raises-pre-series-a-round-from-3one4-capital-rainmatter-and-others-11021693 Content: Materials science company Zerocircle has raised Rs 5 crore in a pre-Series A funding round co-led by 3one4 Capital and Rainmatter Capital along with participation from other investors. The Pune-based company had earlier raised Rs 20 crore ($2.3 million) in a funding round led by Zerodha co-founder Nithin Kamath’s Rainmatter, with participation from early-stage venture capital firms 1Crowd, VC Grid, 7th Gen Ventures, and environmental advocate Trudie Styler, among others. The proceeds will be used to support its deeptech research and scale-up efforts focused on replacing plastic in food and consumer packaging using natural polymers and compounds. Founded in 2020 by Neha Jain, Zerocircle creates seaweed-based packaging designed to replace harmful petrochemical-based materials. Its product range includes coated packaging for hamburger boxes, fried food containers, bakery packaging, and food trays. The company’s materials are designed to eliminate toxic plastics and reduce microplastic leakage into the human body, soil, air, and oceans. According to Zerocircle, its materials are targeted at high-volume packaging categories where incumbent solutions such as polyethylene (PE) and PLA face performance, recyclability, or regulatory constraints. These include foodservice and QSR packaging, coated paper and board, hot and cold beverage cups, grease-resistant food wraps, and biopolymer pellet applications—segments that represent a significant share of global demand and are actively seeking plastic-free, scalable alternatives. The global packaging market is estimated at over $1.1 trillion, with the sustainable alternatives segment projected to grow to $530–560 billion by 2030. Zerocircle focuses on scaling in markets where regulatory pressure and customer demand for plastic-free packaging are accelerating, including Europe, the UK, Oceania, and India. The company works closely with distributors, converters, and foodservice partners to deploy its materials across high-volume applications such as food packaging and coated paper products. Zerocircle is close to launching a new portfolio of barrier coatings, including water-resistant coated paperboards, heat-sealable coatings for applications such as cutlery pouches in hospitality, and coated low-GSM paper for food wraps and liners. Over the past year, Zerocircle claims it has replaced approximately 1.6 million plastic food containers with deployments across India, the Netherlands, and the Benelux region of Europe.

Genexis Biotech raises Rs 4 Cr in seed round led by GVFL

EntrackrEntrackr · 6m ago
Genexis Biotech raises Rs 4 Cr in seed round led by GVFL
Medial

Genexis Biotech raises Rs 4 Cr in seed round led by GVFL Vadodara-based bio-manufacturing startup Genexis Biotech has raised Rs 4 crore in a seed funding round led by GVFL, with participation from Benzai10. The proceeds will be used to scale bioreactor capacity, build downstream processing infrastructure, launch new recombinant proteins and enzymes, and strengthen compliance, sales, and distribution functions. Genexis Biotech develops animal-origin-free recombinant proteins using precision fermentation, catering to sectors like biopharma, food-tech, and cell culture. The startup operates a certified Class 10,000 facility and is setting up a GMP-compliant unit. It has introduced recombinant peptidases such as amino peptidase and enterokinase, and plans to launch recombinant transferrin and albumin. In the past year, Genexis established partnerships with pharmaceutical companies and biotech firms, signed an MoU with the Gujarat government, and received client orders for alternative protein formulations. It showcased its portfolio at Global Bio-India 2024 and aims to enter the regulated biotech export market, develop encapsulated formulations for the cosmetics industry, and collaborate with CDMOs, academic labs, and biopharma firms. Genexis Biotech focuses on scalable, ethical biomolecule production. GVFL has backed the company as part of its investment thesis across deeptech and biotech innovation.

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group

EntrackrEntrackr · 7m ago
Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group
Medial

Lamark Biotech raises Rs 6.5 Cr in pre-Series A round led by IAN Group Lamark's proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. Biopharma startup Lamark Biotech has raised Rs 6.5 crore in a pre-Series A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Vinayender Tulla, Nita Roy, and Venkataraman KNK. Domain experts from IAN’s angel investors led the round. The Ahmedabad-based company had previously raised $41.3K in a seed funding round led by VIT-TBI and others. The fresh funds will be utilized to accelerate the development of thermostable insulin and expand the biologics platform for global access, Lamark said in a press release. Founded in 2018 by Vaibhav Bhatia, Lamark Biotech aims to reimagine drug delivery for chronic and life-altering diseases. Its proprietary ProteoStrong platform enables the stabilization of fragile protein-based drugs, such as insulin, monoclonal antibodies, and enzymes, without altering their molecular structure. According to Lamark Biotech, it leverages the R&D base of Venture Center, NCL Innovation, and it is advancing a new class of temperature-resilient biologics that retain potency across extreme conditions—ideal for underserved regions where cold storage infrastructure is limited. With its lead program, InsulinStrong, Lamark is targeting the Rs 4,000 crore Indian insulin market and intends to expand across Southeast Asia and the UAE. In the next 24 months, it plans to file new international patents, begin early clinical trials, and build partnerships with pharma companies, CDMOs, and global health agencies.

Exclusive: SolarSquare raises fresh funds from Zerodha's Rainmatter, Gruhas, others

EntrackrEntrackr · 1y ago
Exclusive: SolarSquare raises fresh funds from Zerodha's Rainmatter, Gruhas, others
Medial

Rooftop solar startup SolarSquare has raised $4.2 million from existing investors Zerodha’s Rainmatter Capital, Abhijeet Pai and Nikhil Kamath’s Gruhas Proptech, Lowercrabon Capital, Climate Angels and Good Capital. The board at SolarSquare has passed a special resolution to allot 7,589 Series B compulsory convertible debentures at an issue price of Rs 46,710 to raise Rs 35.44 crore, its regulatory filing shows. Lowercarbon and Good Capital invested Rs 20.74 crore and 3.32 crore while Gruhas Proptech and Rainmatter separately pumped in Rs 6.22 crore and Rs 3.98 crore, respectively. The funding will be used for the expansion, working capital requirements, and general corporate purposes, according to the filings. Every debenture issue during the round will be converted into a preference share at the next qualified funding round and the investors are considering the same to take place at a valuation of $75 million, the filings further added. As per TheKredible estimates, the company has been valued at around Rs 394 crore or $48 million post-allotment. The company is likely to raise more funds in this round and the valuation may vary after the final tranche. SolarSquare has raised over $20 million to date including its Rs 100 crore ($12 million) Series A round led by Elevation Capital and Lowercarbon in November 2022. According to the startup data intelligence platform TheKredible, Lowercrabon is the largest external stakeholder with 20.29% followed by Elevation Capital which holds 14.99%. Rainmatter and Gruhas Proptech own 3.84% and 2.50% respectively in SolarSquare. Head to TheKredible for the complete shareholding pattern. Founded by Neeraj Jain and Nikhil Nahar, SolarSquare designs, installs, and finances rooftop solar systems for homes. It also provides rooftop solar solutions for housing societies and commercial establishments. The company is yet to file its financial statements for FY24 but its revenue from operations grew 35.4% to Rs 107 crore in FY23. It posted Rs 35 crore loss in the same period. SolarSquare competes with Zunroof, Cleantech, Mysun, Oorjan, and Freyr Energy, among others. In February, the company acquired PV Diagnostics, a company with expertise in the utility scale solar power sector. Update: The story and headline have been updated to reflect Zerodha Technology as Zerodha’s Rainmatter Capital.

Allo Health raises Rs 16 Cr in pre-Series A round

EntrackrEntrackr · 10m ago
Allo Health raises Rs 16 Cr in pre-Series A round
Medial

Allo Health raises Rs 16 Cr in pre-Series A round Sexual health startup Allo Health has raised Rs 16 crore ($1.83 million) in its pre-Series A round led by Rainmatter along with existing investors. Prior to this round, Allo had raised $4.4 million in seed funding led by Nexus Venture Partners, with participation from founders and operators, including Binny Bansal (Flipkart), Deepinder Goyal (Zomato), Rohit MA (Cloudnine), and Sandeep Singhal (Nexus). The proceeds will be used to ramp up clinic densification, invest in deeper technology capabilities, and enhance patient engagement as Allo continues to scale. Founded by Pranay Jivrajka, Allo has built a hybrid ecosystem that combines physical clinics, AI-powered treatment protocols, and trained medical professionals. Allo’s proprietary doctor training programs, AI-powered clinical decision support, and research-backed treatment helps it manage effectively. Since its inception, Allo claims to have treated over 200,000 patients across India, achieving a 85% improvement in patient outcomes, with over 35 clinics across major cities, including Bangalore, Mumbai, Pune, Hyderabad, Chennai, Mysore, and Ranchi.

Terafac raises Rs 6.5 Cr in pre-seed round led by Inuka Capital

EntrackrEntrackr · 5m ago
Terafac raises Rs 6.5 Cr in pre-seed round led by Inuka Capital
Medial

Terafac raises Rs 6.5 Cr in pre-seed round led by Inuka Capital Chandigarh-based AI-robotics startup Terafac has raised Rs 6.5 crore ($800K) in a pre-seed round led by Inuka Capital. Other investors include DEVC, Bharat Founders Fund, Innovation Mission Punjab, and select angels. The proceeds will be used for product innovation, market expansion, and hiring. Founded by Anubhi Khandelwal and Amrit Singh, Terafac has developed an AI-Vision platform that converts standard industrial robots into intelligent, self-adjusting machines. Its first product, WeldT, automates welding using computer vision to handle high product variations. The startup plans to expand its solution across tasks like gluing, painting, and inspection. Terafac operates on a "Software-as-a-Skill" model and targets 80 deployments across 20 customers in the next year. Its business model revolves around providing AI-based manufacturing automation tools to OEMs and factories, aiming to reach Rs 8 crore in ARR by FY26.

Download the medial app to read full posts, comements and news.